In a time of increasing diffusion of personalized medicine, longitudinal studies specifically designed to assess the effectiveness of treatments promoting the preservation and recovery of β-cell function and that of insulin sensitivity in non-obese individuals with diabetes should be encouraged. This evidence concerns the gene INS and diabetes mellitus.